Tag Archives: Ministry of Defence (UK)

Television News Coverage of the UK Parliamentary Inquiry Report on Lariam in the Military

The British Parliament’s Defence Select Committee published its report, “An acceptable risk? The use of Lariam for military personnel” on Tuesday 24 May 2016. Here are several of the television news stories that followed the publication of this report. Advertisements

Posted in Advocacy, Media, Our Stories, Uncategorized | Tagged , , , , , , | Leave a comment

Johnny Mercer MP: “The Ministry of Defence has Betrayed Our Armed Forces’ Mental Health”

For many years, British service personnel have been treated with a controversial anti-malaria drug despite warnings issued by its manufacturer. The Commons defence select committee, of which I am a member, has heard from scientists, lawyers and servicemen to try … Continue reading

Posted in Advocacy, Media | Tagged , , , , , , , , , , | Leave a comment

British Parliamentary Inquiry: “Lariam Should be ‘Drug of Last Resort’ for Troops”

  Lariam, the anti-malarial drug sometimes prescribed to British troops, should be considered only as a drug of last resort, says the Defence Committee, in its report on the MoD’s use of the drug. Report: An acceptable risk? The use … Continue reading

Posted in Advocacy, Research | Tagged , , , , , , , , , | Leave a comment

British Army Medical Officer on Existing Treatments for Lariam Depression: “All They Do is Stick a Plaster Over It”

Maj Mick Wallace took Lariam during his deployment in Kenya in 1998, and he says he has been severely depressed ever since: “When I came back my wife said I wasn’t the same man. I was short-tempered, anxious at times. … Continue reading

Posted in Media, Our Stories | Tagged , , , , , , , , | Leave a comment

General Richards: “If the Use of Lariam is Banned it Would Not Be Before Time”

Kim Sengupta, British armed forces set to ban most prescriptions of controversial anti-malarial drug Lariam, The Independent, 23 May 2016. A number of senior officers say that recognition of the dangerous side-effects that the use of Lariam  is long overdue. General … Continue reading

Posted in Advocacy, Media | Tagged , , , , , , , , , | Leave a comment

British Mefloquine Veteran Resorts to Legal Action: “They Just Put Everything Down to PTSD”

A large proportion of veterans afflicted by mefloquine toxicosis have unfortunately been misdiagnosed with post-traumatic stress disorder (PTSD). Although the symptoms of mefloquine toxicosis can be similar to PTSD, careful examination by health professionals should result in proper diagnosis and … Continue reading

Posted in Advocacy, Media, Research, Support | Tagged , , , , , , , | Leave a comment

Philippa Tuckman – Lariam for Military Personnel: An Unacceptable Risk

The House of Commons Defence Committee will publish its report An acceptable risk? The use of Lariam for military personnel  on 24thMay. Having both given evidence to the inquiry and carefully considered the submissions of other witness, I am hopeful … Continue reading

Posted in Advocacy, Support | Tagged , , , , , , , , , | Leave a comment

Daily Express: Ministry of Defence Accused of ‘Negligence on a Grand Scale’ As Troops Sue Over Lariam (Mefloquine)

BRITISH troops who say they were left with serious mental health side effects after taking a controversial anti-malaria drug are taking legal action against the Ministry of Defence. The group of armed forces veterans say they have suffered hallucinations, severe … Continue reading

Posted in Advocacy, Media, Support | Tagged , , , , , , , | 2 Comments

British Parliamentary Inquiry Report on the Use of Lariam™ (Mefloquine) for Military Personnel to be Published on 24 May 2016

The British Parliament’s Defence Select Committee is publishing its report, “An acceptable risk? The use of Lariam for military personnel” on Tuesday 24 May 2016 at 00.01am. Report This is the Committee’s Fourth Report of Session 2015–16 (HC 567) and it can … Continue reading

Posted in Advocacy, Clinical Drug Trials, Media, Our Stories | Tagged , , , , , , , , , , , , | 1 Comment